Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Elevated urine phosphoethanolamine (PEA) signals that alkaline phosphatase (ALP) is not breaking down its natural substrates, a pattern that helps confirm hypophosphatasia and distinguish it from other bone and mineral disorders. Because PEA, inorganic pyrophosphate, and pyridoxal 5'-phosphate all build up when ALP activity is low, clinicians read these substrate levels alongside serum ALP, imaging, symptoms, and ALPL gene testing rather than in isolation. Age-specific reference ranges matter, since PEA can also rise modestly in other conditions and can look normal in milder cases, so a single result rarely settles the diagnosis. There are several important factors and testing caveats to consider before drawing conclusions, and they are explained in the complete answer below.
If unexplained bone pain, frequent fractures, early tooth loss, or muscle weakness brought you here, the fastest way to organize your next steps is to describe what you are experiencing and see which conditions and specialists fit the pattern; a free, instant, online symptom check takes only a few minutes, is private, and can help you arrive at your appointment with clearer questions and a stronger sense of what to ask your doctor to test.
Last reviewed for medical accuracy: 08/18/2026
Hypophosphatasia (HPP) is a rare genetic disorder marked by deficient activity of the enzyme alkaline phosphatase (ALP). One of the key biochemical clues in diagnosing HPP is elevated levels of phosphoethanolamine (PEA) in the urine. This article explains how ALP substrate testing works, what high urine PEA levels mean, and how a Phosphoethanolamine urine test for HPP fits into a comprehensive diagnostic approach.
Alkaline phosphatase (ALP) is an enzyme that helps break down certain phosphate-containing compounds, including PEA, a molecule involved in cell membrane metabolism and bone mineralization. When ALP activity is normal, PEA is dephosphorylated in tissues and excreted at low levels in the urine. In HPP, mutations in the ALPL gene reduce ALP activity, leading to:
Measuring urine PEA provides a non-invasive window into ALP function. Elevated PEA levels point to inadequate dephosphorylation by ALP, supporting a diagnosis of HPP when aligned with clinical findings.
Sample Collection
Analytical Methods
These techniques separate PEA from other urinary compounds and quantify it with high sensitivity. Laboratories calibrate assays using known PEA standards, ensuring reliable reference ranges.
Reference Ranges and Cutoffs
Interpreting Results
By adding a urine PEA measurement to the diagnostic workup, clinicians can:
HPP manifestations vary widely, classified by age at onset:
Symptoms can be subtle, especially in adult or odontohypophosphatasia forms. If you’ve experienced recurrent stress fractures, unexplained bone pain, or early tooth loss, consider evaluating your risk. You can also do a free, online symptom check, using the doctor approved Ubie Symptom Checker to guide your next steps.
Initial Evaluation
Biochemical Panel
Genetic Testing
Imaging Studies
Pros of urine PEA testing:
Limitations:
Confirming HPP opens the door to targeted treatments and monitoring:
Regular follow-up includes:
While a Phosphoethanolamine urine test for HPP provides valuable insight, it’s only one piece of the puzzle. If you have:
…you should speak to a doctor. They can interpret test results, recommend genetic counseling, and design an individualized treatment plan. In emergencies or signs of severe disease (e.g., breathing difficulties in infants), seek immediate medical attention.
This overview should help you understand how high urine PEA levels aid in diagnosing HPP through ALP substrate testing. Always consult a qualified healthcare professional for personal advice, and consider using the doctor-approved Ubie Symptom Checker for a free, online symptom check to guide your next steps.
(References)
* Meberg A, Torstenson T. [Hypophosphatasia]. Tidsskr Nor Laegeforen. 1974 Apr;94(10):641-3. PMID: 4826792.
* Mornet E. Hypophosphatasia. Orphanet J Rare Dis. 2007 Oct 4;2:40. doi: 10.1186/1750-1172-2-40. Epub 2007 Oct 4. PMID: 17916236; PMCID: PMC2164941.
* Whyte MP. Hypophosphatasia: An overview For 2017. Bone. 2017 Sep;102:15-25. doi: 10.1016/j.bone.2017.02.011. Epub 2017 Feb 24. PMID: 28238808.
* Fenn JS, Lorde N, Ward JM, Borovickova I. Hypophosphatasia. J Clin Pathol. 2021 Oct;74(10):635-640. doi: 10.1136/jclinpath-2021-207426. Epub 2021 Apr 30. PMID: 33931563.
* Riancho JA. Diagnostic Approach to Patients with Low Serum Alkaline Phosphatase. Calcif Tissue Int. 2023 Mar;112(3):289-296. doi: 10.1007/s00223-022-01039-y. Epub 2022 Nov 8. PMID: 36348061.
* Reis FS, Lazaretti-Castro M. Hypophosphatasia: from birth to adulthood. Arch Endocrinol Metab. 2023 May 25;67(5):e000626. doi: 10.20945/2359-3997000000626. PMID: 37249457; PMCID: PMC10665056.
* Whyte MP, McAlister WH, Mack KE, Mumm S, Madson KL. Pediatric hypophosphatasia: avoid diagnosis missteps! J Bone Miner Res. 2024 Jul 23;39(6):655-660. doi: 10.1093/jbmr/zjae098. PMID: 38905292.
* Seefried L, Genest F, Hofmann C, Brandi ML, Rush E. Diagnosis and Treatment of Hypophosphatasia. Calcif Tissue Int. 2025 Mar 6;116(1):46. doi: 10.1007/s00223-025-01356-y. Epub 2025 Mar 6. PMID: 40047955; PMCID: PMC11885340.
* Buyukyilmaz G, Koca SB, Gören R, Uzdogan A, Adıguzel KT, Uğurlu AK, Yardimci G, Kocaay P, Tepe D, Boyraz M, Kilic E, Gürbüz F. Evaluation of Low Alkaline Phosphatase Levels in Clinical Practice: Implications for Diagnosing Hypophosphatasia. Calcif Tissue Int. 2025 Aug 19;116(1):111. doi: 10.1007/s00223-025-01424-3. Epub 2025 Aug 19. PMID: 40828320.
* Kishnani PS, Seefried L, Ozono K, Martos-Moreno GÁ, Rockman-Greenberg C, Fowler D, Burke LK, Mowrey WR, Rush ET, Ebeling PR, Högler W, Linglart A, Fang S, Petryk A, Dahir KM. The Global Hypophosphatasia Registry: lessons learned from a decade of real-world data. Orphanet J Rare Dis. 2025 Nov 24;20(1):626. doi: 10.1186/s13023-025-04129-w. Epub 2025 Nov 24. PMID: 41286962; PMCID: PMC12751868.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.